GoBalto names new CEO as Chung becomes president; 23andMe stops offering analysis of genetic data;

> GoBalto has named Sujay Jadhav as CEO, with former chief Jae Chung taking the role of president. News

> 23andMe has stopped providing analysis of genetic data in response to an FDA warning letter. Article

> A report has suggested Big Data can help biopharma clear the clinical trial enrollment bottleneck. Item

> CRO SPRI Clinical Trials has joined the Datatrak Connect partnership program. Release

> Appistry has added Broad Institute next-generation sequencing (NGS) analysis tools to its cancer genome suite. News

> A computational method to predict protein configurations could aid novel drug design. Study

> Belgium-based e-novex has introduced a cloud-based EDC system, edc2go. Post

> An Indian bioinformatics business is setting up a genomics center in San Francisco. Piece

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.